Literature DB >> 29444726

Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.

J Ferri1, J M Ford1, B J Roach2, J A Turner3, T G van Erp4, J Voyvodic5, A Preda4, A Belger6, J Bustillo7, D O'Leary8, B A Mueller9, K O Lim9, S C McEwen10, V D Calhoun3, M Diaz5, G Glover11, D Greve12, C G Wible13, J G Vaidya8, S G Potkin4, D H Mathalon1.   

Abstract

BACKGROUND: Schizophrenia (SZ) is a severe neuropsychiatric disorder associated with disrupted connectivity within the thalamic-cortico-cerebellar network. Resting-state functional connectivity studies have reported thalamic hypoconnectivity with the cerebellum and prefrontal cortex as well as thalamic hyperconnectivity with sensory cortical regions in SZ patients compared with healthy comparison participants (HCs). However, fundamental questions remain regarding the clinical significance of these connectivity abnormalities.
METHOD: Resting state seed-based functional connectivity was used to investigate thalamus to whole brain connectivity using multi-site data including 183 SZ patients and 178 matched HCs. Statistical significance was based on a voxel-level FWE-corrected height threshold of p < 0.001. The relationships between positive and negative symptoms of SZ and regions of the brain demonstrating group differences in thalamic connectivity were examined.
RESULTS: HC and SZ participants both demonstrated widespread positive connectivity between the thalamus and cortical regions. Compared with HCs, SZ patients had reduced thalamic connectivity with bilateral cerebellum and anterior cingulate cortex. In contrast, SZ patients had greater thalamic connectivity with multiple sensory-motor regions, including bilateral pre- and post-central gyrus, middle/inferior occipital gyrus, and middle/superior temporal gyrus. Thalamus to middle temporal gyrus connectivity was positively correlated with hallucinations and delusions, while thalamus to cerebellar connectivity was negatively correlated with delusions and bizarre behavior.
CONCLUSIONS: Thalamic hyperconnectivity with sensory regions and hypoconnectivity with cerebellar regions in combination with their relationship to clinical features of SZ suggest that thalamic dysconnectivity may be a core neurobiological feature of SZ that underpins positive symptoms.

Entities:  

Keywords:  Thalamus; connectivity; resting-state fMRI; schizophrenia

Mesh:

Year:  2018        PMID: 29444726     DOI: 10.1017/S003329171800003X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  24 in total

1.  Increased Thalamocortical Connectivity in Schizophrenia Correlates With Sleep Spindle Deficits: Evidence for a Common Pathophysiology.

Authors:  Bengi Baran; Fikret Işık Karahanoğlu; Dimitrios Mylonas; Charmaine Demanuele; Mark Vangel; Robert Stickgold; Alan Anticevic; Dara S Manoach
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-05-08

2.  Increased global cognition correlates with increased thalamo-temporal connectivity in response to targeted cognitive training for recent onset schizophrenia.

Authors:  Ian S Ramsay; Brian J Roach; Susanna Fryer; Melissa Fisher; Rachel Loewy; Judith M Ford; Sophia Vinogradov; Daniel H Mathalon
Journal:  Schizophr Res       Date:  2020-01-29       Impact factor: 4.939

Review 3.  Disrupted Corollary Discharge in Schizophrenia: Evidence From the Oculomotor System.

Authors:  Katharine N Thakkar; Martin Rolfs
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-04-02

4.  Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial.

Authors:  Samantha V Abram; Lize De Coster; Brian J Roach; Bryon A Mueller; Theo G M van Erp; Vince D Calhoun; Adrian Preda; Kelvin O Lim; Jessica A Turner; Judith M Ford; Daniel H Mathalon; Joshua D Woolley
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

5.  Cortico-thalamic dysconnection in early-stage schizophrenia: a functional connectivity magnetic resonance imaging study.

Authors:  Mu-Hong Chen; Wan-Chen Chang; Ya-Mei Bai; Kai-Lin Huang; Pei-Chi Tu; Tung-Ping Su; Cheng-Ta Li; Wei-Chen Lin; Shih-Jen Tsai; Ju-Wei Hsu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-04-05       Impact factor: 5.270

6.  Reconciling competing mechanisms posited to underlie auditory verbal hallucinations.

Authors:  Katharine N Thakkar; Daniel H Mathalon; Judith M Ford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-12-14       Impact factor: 6.237

7.  Tri-Clustering Dynamic Functional Network Connectivity Identifies Significant Schizophrenia Effects Across Multiple States in Distinct Subgroups of Individuals.

Authors:  Md Abdur Rahaman; Eswar Damaraju; Jessica A Turner; Theo G M van Erp; Daniel Mathalon; Jatin Vaidya; Bryon Muller; Godfrey Pearlson; Vince D Calhoun
Journal:  Brain Connect       Date:  2021-07-30

8.  Improvement in prefrontal thalamic connectivity during the early course of the illness in recent-onset psychosis: a 12-month longitudinal follow-up resting-state fMRI study.

Authors:  Daniel Bergé; Tyler A Lesh; Jason Smucny; Cameron S Carter
Journal:  Psychol Med       Date:  2020-12-16       Impact factor: 10.592

9.  Genetic Contribution of Synapse-Associated Protein 97 to Orbitofrontal-Striatal-Thalamic Circuitry Connectivity Changes in First-Episode Schizophrenia.

Authors:  Xusan Xu; Shucun Luo; Xia Wen; Xiaoxia Wang; Jingwen Yin; Xudong Luo; Bin He; Chunmei Liang; Susu Xiong; Dongjian Zhu; Jiawu Fu; Dong Lv; Zhun Dai; Juda Lin; You Li; Zhixiong Lin; Wubiao Chen; Zebin Luo; Yajun Wang; Guoda Ma
Journal:  Front Psychiatry       Date:  2021-07-19       Impact factor: 4.157

10.  Thalamus Radiomics-Based Disease Identification and Prediction of Early Treatment Response for Schizophrenia.

Authors:  Long-Biao Cui; Ya-Juan Zhang; Hong-Liang Lu; Lin Liu; Hai-Jun Zhang; Yu-Fei Fu; Xu-Sha Wu; Yong-Qiang Xu; Xiao-Sa Li; Yu-Ting Qiao; Wei Qin; Hong Yin; Feng Cao
Journal:  Front Neurosci       Date:  2021-07-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.